The first drug to slow the destruction of the brain in Alzheimer's has been heralded as momentous. The research breakthrough ends decades of failure and shows a new era of drugs to treat Alzheimer ...

Chemotherapeutic and biotherapeutic drugs are the main areas of fund investment ... transfer of research output in chemotherapy, biotherapy and physiotherapy, while China's prominent contribution ...

Though many chemotherapy drugs can have certain side effects but ... done in cancer treatment and many new targeted agents and biotherapy molecule, are coming up which are as good as or better ...

Every day seems to bring more exciting news. First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to treat cardiovascular and ...

State Key Laboratory of Biotherapy (SKLB), belongs to the West ... Platforms for Novel Drugs founded by the Ministry of Sciences and Technology as well as the Ministry of Health in 2008.

When a medication works right, it boosts your health or helps you feel better. But a drug can bring on problems if it doesn't mix well with something else you put into your body, like another ...

Efficient technology transfer is crucial in biotherapy manufacturing to ensure consistent product quality across multiple sites, regulatory compliance and timely market entry. In this webinar, you ...

It's an age-old worry among many parents: Is my kid using drugs? Data shows why such concerns these days go beyond fretting over a teen potentially puffing on pot, with the rise of fentanyl ...

Drug-induced lupus is more common in men because they are given these drugs more often; however, not everyone who takes these drugs will develop the disease. Specific criteria for diagnosing ...

You've applied for a job and received an offer of employment, but there is one last step before the position is yours: a pre-employment drug test. For a range of jobs, particularly in the public ...

Alzheimer's patients could lose out on two groundbreaking new drugs because the NHS is unprepared, a leading charity has told BBC Panorama. Lecanemab and donanemab slow down the early stages of ...